Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's metadata.SummaryDifference0.1%

- Check15 days agoChange Detected- A new funding attribution line '2018 ( U.S. NIH Grant/Contract )' was added to the study identifiers section. This indicates NIH support for the trial.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a deployment update and does not alter the study information presented.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4, representing a small, non-substantive update to the page version.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision label updated from Revision: v3.6.0 to Revision: v3.6.3, indicating a backend or UI update rather than a change to the study details.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded the study's responsible party name (Luis F. Lopez-Cortes) and status indicators (Last verified; Last known status was), along with new navigation links (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment label with a revision update to v3.6.0. The previous items and formatting (Last known status was; Verified; Luis F. Lopez-Cortes; Hospitales Universitarios Virgen del Rocío; Intervention / Treatment; Revision: v3.5.5) were removed or reformatted.SummaryDifference2%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.